… After proving that Ad-F+Ad-IL-1β is an effective vaccine candidate that establishes systemic
and mucosal immunity, we compared its immunogenicity profile and protective efficacy to …

… of mucosal immunity suggests that mucosal vaccination is far … the use of adenoviral vector
at mucosal sites for infectious … models have suggested that adenoviral vectors are effective in …

… route of rAd vector delivery critically impacted both systemic and mucosal immunity. In
particular… T-lymphocyte responses among the systemic and mucosal compartments. In contrast, ig …

… Since parenteral immunization with an adenovirus vector expressing gB … mucosal
immunization would stimulate mucosal immune responses and provide protection at the mucosal …

… adenoviral vectors including nonhuman adenoviral vectors … In this review, we discuss the
latest adenoviral technologies and … of adenoviral-vectored vaccines in mucosal immunization …

… However, respiratory mucosal vaccination in humans may require consideration of the use
… adenoviral vectors for enhanced safety (ie different from the conventional adenoviral vector …

… titer in the sera and in the respiratory mucosa. Bronchoalveolar lavage from intranasally
immunized … application of adenoviral vector ChAdOx1-S induces superior mucosal immunity and …

… The use of adenovirus as a mucosal vaccine vector is attractive because serotypes 4 and
7 have been proven safe and effective when administered to millions of military recruits over …

… with adenovirus 5 … mucosal immunity in mice. In contrast to two intramuscular applications
of an mRNA vaccine, intranasal boosts with adenoviral vectors induce high levels of mucosal …

… , and conjunctivitis in humans while inducing a strong innate and adaptive immune response,
making adenovirus (Ad)-based vectors an attractive vaccine platform [20]. Recombinant …